APA (7th ed.) Citation

B, F. D. C., A, F., M, T. U., JE, U., WA, A., M, M., . . . AD, P. (2025). Nanostructured lipid carriers-loaded dry powder inhaler for pulmonary delivery of amphotericin B in treatment of allergic bronchopulmonary aspergillosis. International journal of pharmaceutics, 682, 125926. https://doi.org/10.1016/j.ijpharm.2025.125926

Chicago Style (17th ed.) Citation

B, Florensia Dana Carla, Fachriza A, Thaufik Umar M, Unawekla JE, Anggraini WA, Mir M, Alsayed AR, and Permana AD. "Nanostructured Lipid Carriers-loaded Dry Powder Inhaler for Pulmonary Delivery of Amphotericin B in Treatment of Allergic Bronchopulmonary Aspergillosis." International Journal of Pharmaceutics 682 (2025): 125926. https://doi.org/10.1016/j.ijpharm.2025.125926.

MLA (9th ed.) Citation

B, Florensia Dana Carla, et al. "Nanostructured Lipid Carriers-loaded Dry Powder Inhaler for Pulmonary Delivery of Amphotericin B in Treatment of Allergic Bronchopulmonary Aspergillosis." International Journal of Pharmaceutics, vol. 682, 2025, p. 125926, https://doi.org/10.1016/j.ijpharm.2025.125926.